Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide Resistance.

× No keyword cloud information.

13 in total

1. Proficiency testing of first- and second-line anti-tuberculosis drugs in Italy.

Authors: Lanfranco Fattorini; Giovanni Battista Migliori; Antonio Cassone; Alessandro Mustazzolu; Giovanni Piccaro; Perla Filippini; Daniela Maria Cirillo; Emanuele Borroni
Journal: Eur Respir J Date: 2012-05 Impact factor: 16.671

2. Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.

Authors: Pamela Chedore; Lina Bertucci; Joyce Wolfe; Meenu Sharma; Frances Jamieson
Journal: J Clin Microbiol Date: 2009-11-18 Impact factor: 5.948

3. Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience.

Authors: S Hoffner; K Angeby; E Sturegård; B Jönsson; A Johansson; M Sellin; J Werngren
Journal: Int J Tuberc Lung Dis Date: 2013-11 Impact factor: 2.373

Review 4. Mechanisms of Pyrazinamide Action and Resistance.

Authors: Ying Zhang; Wanliang Shi; Wenhong Zhang; Denis Mitchison
Journal: Microbiol Spectr Date: 2014-08

Review 5. Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates.

Authors: Sarah M Ramirez-Busby; Faramarz Valafar
Journal: Antimicrob Agents Chemother Date: 2015-06-15 Impact factor: 5.191

6. Validation of pncA gene sequencing in combination with the mycobacterial growth indicator tube method to test susceptibility of Mycobacterium tuberculosis to pyrazinamide.

Authors: Sami O Simons; Jakko van Ingen; Tridia van der Laan; Arnout Mulder; P N Richard Dekhuijzen; Martin J Boeree; Dick van Soolingen
Journal: J Clin Microbiol Date: 2011-11-16 Impact factor: 5.948

7. Characterisation of pncA mutations in clinical Mycobacterium tuberculosis isolates in New Zealand.

Authors: Sushil Pandey; Sandie Newton; Arlo Upton; Sally Roberts; Dragana Drinković
Journal: Pathology Date: 2009 Impact factor: 5.306

8. Prevention of false resistance results obtained in testing the susceptibility of Mycobacterium tuberculosis to pyrazinamide with the Bactec MGIT 960 system using a reduced inoculum.

Authors: Claudio Piersimoni; Alessandro Mustazzolu; Federico Giannoni; Stefano Bornigia; Giancarlo Gherardi; Lanfranco Fattorini
Journal: J Clin Microbiol Date: 2012-10-24 Impact factor: 5.948

9. Pyrazinamide susceptibility testing: proposed new standard with the BACTECTM MGITTM 960 system.

Authors: C Piersimoni; A Mustazzolu; A Iacobino; F Giannoni; G Santoro; G Gherardi; A Del Giudice; R Perna; L Fattorini
Journal: Int J Tuberc Lung Dis Date: 2016-12 Impact factor: 2.373

10. A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis.

Authors: S M Ramirez-Busby; T C Rodwell; L Fink; D Catanzaro; R L Jackson; M Pettigrove; A Catanzaro; F Valafar
Journal: Sci Rep Date: 2017-06-19 Impact factor: 4.379

1 in total

1. Structural and free energy landscape of novel mutations in ribosomal protein S1 (rpsA) associated with pyrazinamide resistance.

Authors: Muhammad Tahir Khan; Abbas Khan; Ashfaq Ur Rehman; Yanjie Wang; Khalid Akhtar; Shaukat Iqbal Malik; Dong-Qing Wei
Journal: Sci Rep Date: 2019-05-16 Impact factor: 4.379

1 in total